Idrees Muhammad,
Frederick Leo Sossah,
Yang Yang,
Dan Li,
Shoujian Li,
Yongping Fu* and
Yu Li*
Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, Jilin Agricultural University, Changchun, 130118, P. R. China. E-mail: yongpingfu81@126.com; yuli966@126.com; Tel: +86-431-8453-2989
First published on 14th May 2019
Outbreaks of cobweb disease are becoming increasingly prevalent globally, severely affecting the quality and yield of Agaricus bisporus. However, cobweb disease-resistant strains are rare, and little is known regarding the biocontrol management of the disease. Here, we isolated a pathogen from a severe outbreak of cobweb disease on A. bisporus in China and identified it as Cladobotryum mycophilum based on morphological characteristics, rDNA sequences, and pathogenicity tests. We then tested 30 A. bisporus strains for cobweb disease resistance by inoculating with C. mycophilum and evaluated the activity of different botanicals. We found that two wild strains of A. bisporus originating from the Tibetan Plateau in China were resistant to cobweb disease, and four commercial strains were susceptible. Yield comparisons of the inoculated and uninoculated strains of A. bisporus with C. mycophilum revealed yield losses of 6–38%. We found that seven botanicals could inhibit C. mycophilum growth in vitro, particularly Syzygium aromaticum, which exhibited the maximum inhibition (99.48%) and could thus be used for the further biocontrol of cobweb disease. Finally, we identified the bioactive chemical constituents present in S. aromaticum that could potentially be used as a treatment for C. mycophilum infection using Fourier transform infrared (FTIR) spectroscopy. These findings provide new germplasm resources for enhancing A. bisporus breeding and for the identification of botanicals for the biocontrol of cobweb disease.
Agaricus bisporus, commonly known as button mushroom, is a widely cultivated edible mushroom that is high in protein and low in fat. With the expansion of the commercial cultivation of these mushrooms, the occurrence of fungal diseases on A. bisporus has also increased. In 2016, cobweb disease with an incidence of 2–5% on a commercial A. bisporus farm in China was first identified as being caused by C. mycophilum.10 Though the resistance of A. bisporus strains to different pathogens has been studied,11–13 an evaluation of cobweb disease resistance/susceptibility to Cladobotryum species has neither been detected nor well characterized.
Fungicide application is not suitable for palatable mushrooms owing to their residual toxicity.14 Furthermore, some species of Cladobotryum are resistant to fungicides.15 Previous studies have shown that certain plant extracts exhibit antimicrobial activity and have been used traditionally for the treatment of plant and animal diseases,16–19 such as Mentha longifolia, Allium sativum, and Syzygium aromaticum. The application of these substances of natural origin as mushroom crop protectants could constitute a convenient, low-cost, and safe solution for both humans and the environment and is also compatible with the natural ecosystem.
Therefore, to accelerate the breeding of A. bisporus strains with resistance to C. mycophilum and implement disease management approaches for the cultivation of A. bisporus, we designed our study with the following objectives: (1) to screen cultivated and wild strains of A. bisporus in order to identify resistance to C. mycophilum; and (2) to evaluate different botanicals for in vitro antifungal activity towards the cobweb disease pathogen C. mycophilum and assess the molecular spectra of the most effective botanical by Fourier-transform infrared spectroscopy (FTIR).
The pathogenicity of C. mycophilum isolate CMIDR1 was tested using Koch's postulates, conducted on the commercial A. bisporus strain CCMJ1009. CCMJ1009 was cultivated in a controlled incubation and fruiting room at the Edible Mushroom Base of Jilin Agricultural University, China. The cultivation of A. bisporus CCMJ1009 was performed as described in Fu et al. (2016). In the first set of experiments, the spore suspension of C. mycophilum CMIDR1 (7.5 × 103 spores per mL) was prepared on the day of inoculation from a 5 day-old culture on PDA, and then the concentration of the spore suspension was determined by means of a hemocytometer. Healthy fruiting bodies of CCMJ1009 were then inoculated with 50 μL of prepared spore suspension of C. mycophilum maintained at a temperature of 22 °C and 95% humidity.10 Sterilized distilled water (SDW) was used for the control group. In the second set of experiments, a spore suspension of C. mycophilum CMIDR1 (7.5 × 103 spores per mL) was prepared on the 9th day of casing and sprayed onto the surface of the casing layer (20 mL per basket, 35 × 25 × 17 cm), while the control baskets were sprayed with SDW.25 The casing surface was checked daily to examine the isolated outbreaks. The affected area and infected fruiting bodies were treated by covering with damp paper and salt to prevent the dry conidia from being released and to avoid the possibility of cross contamination.6 Then, the pathogen strains from the diseased button and caps were re-isolated and cultured on PDA. Genomic DNA of the pathogen was extracted, and PCR amplification and sequencing of ITS gene was performed. The methods were same as the above mentioned. The sequencing results were compared to the sequence of the CMIDR1 strain.
Strain name | Original reference | Origin | Strain types |
---|---|---|---|
CCMJ1009 | A15 | USA | Cultivated |
CCMJ1013 | As2796 | China | Cultivated |
CCMJ1020 | ZA | Germany | Cultivated |
CCMJ1021 | S130A | USA | Cultivated |
CCMJ1018 | As4580 | China | Cultivated |
CCMJ1028 | S46 | China | Cultivated |
CCMJ1033 | C13 | USA | Cultivated |
CCMJ1035 | 0072 | USA | Cultivated |
CCMJ1037 | U1 | Netherlands | Cultivated |
CCMJ1038 | PSU310 | USA | Cultivated |
CCMJ1039 | 126 | Netherlands | Cultivated |
CCMJ1053 | M-1 | Spain | Cultivated |
CCMJ1109 | Ag23 | England | Cultivated |
CCMJ1343 | W192 | China | Cultivated |
CCMJ1352 | A12 | USA | Cultivated |
CCMJ1106 | 2094 | Tibet, China | Wild |
CCMJ1347 | T12387 | Yunnan, China | Wild |
CCMJ1351 | W2 | Sichuan, China | Wild |
CCMJ1350 | W1 | Sichuan, China | Wild |
CCMJ1360 | W3 | Sichuan, China | Wild |
CCMJ1361 | W4 | Sichuan, China | Wild |
CCMJ1363 | W5 | Sichuan, China | Wild |
CCMJ1369 | W6 | Sichuan, China | Wild |
CCMJ1372 | W7 | Sichuan, China | Wild |
CCMJ1374 | W11 | Sichuan, China | Wild |
CCMJ1377 | W8 | Sichuan, China | Wild |
CCMJ1384 | W10 | Sichuan, China | Wild |
CCMJ1110 | W13 | Shanxi, China | Wild |
CCMJ1379 | W12 | Sichuan, China | Wild |
CCMJ1381 | W9 | Sichuan China | Wild |
Screening and yield loss assessment of the resistance of A. bisporus strains against cobweb disease were performed on March 2017, August 2017, and April 2018. At each assessment, all 30 mushroom strains were cultivated with the same batch of compost and casing soil in twin rooms. The spore suspension was prepared from C. mycophilum CMIDR1, and the inoculation method was the same as mentioned above. For each A. bisporus strain, nine trays were dripped with the spore suspension of C. mycophilum, and another nine trays were dripped with sterile distilled water (20 mL) as a control treatment. After 15–20 days of casing, when the A. bisporus mycelia had fully permeated the casing layer, the room temperature was dropped down to 16–18 °C for fruiting purposes.
The level of resistance of the mushroom strains to cobweb disease caused by C. mycophilum was classified on the basis of visual assessment during the first three flushes by using a modified disease rating scale detailed in Back et al. (2012),15 as follows: 0 = no visible disease development (immune, I); 1 = 1–10% disease severity (resistant, R); 2 = 11–30% disease severity (moderately susceptible, MS); and 3= >30 disease severity (susceptible, S).
The molecular spectra of the most effective botanicals were obtained by FTIR (Bruker, Vertex-70). The ground samples were mixed with potassium bromide (KBr) powder and pressed into tablet-shaped pellets under pressure, and the spectra were recorded at a frequency range of 400–4000 cm−1.28
The isolates of C. mycophilum grew radially and covered the entire Petri plates within 3–4 days. The colonies appeared white in the early stages (Fig. 1C), slowly producing yellow pigments within 5 days, and the entire medium turned red about 10–14 days later (Fig. 1D). The growth rate of these isolates reached 23 mm day−1 on PDA at 25 °C. Chlamydospores were more easily observed on the older mycelia (Fig. 1E). The conidia (n = 50) were transparent, single-celled, oval to oblong with diaphragms, possessed 1–3 septa, and ranged 5.9–13.1 × 9.9–31.0 μm in size. Based on the morphological characteristics, the pathogen was identified as C. mycophilum.
The representative isolate CMIDR1 of C. mycophilum was used for further molecular identification. The generated ITS and tef1 sequences were searched with BLASTn and were found to share 99% similarity with published C. mycophilum sequences in GenBank. The phylogenetic tree based on ITS included other published Cladobotryum sequences (Fig. 2) and showed that CMIDR1(LC422781) clustered with other C. mycophilum accessions and was closely related to C. multiseptatum. Thus, based on the morphological and molecular characteristics, we confirmed that the fungus was C. mycophilum.
We then used Koch's postulates to confirm the pathogenicity of isolate CMIDR1 of C. mycophilum on A. bisporus (Fig. 3). The fruiting bodies developed visible cobweb symptoms on the 4–5th day after inoculation of the CMIDR1 strain. White mycelia of CMIDR1 appeared and spread rapidly on the surfaces of the fruiting bodies of A. bisporus. Disease symptoms were also noticed on the casing surface and then on the primordial and fruiting bodies after 16 days of inoculation. These symptoms were consistent with the symptoms observed in the above-mentioned commercial mushroom cultivation company (Fig. 1A and B) in Hebei province, China. Thus, Koch's postulates confirmed that the pathogen re-isolated from the diseased fruiting bodies of A. bisporus was C. mycophilum.
Fig. 3 Pathogenicity test of C. mycophilum on A. bisporus strain CCMJ1009. (A and B) Symptoms of cobweb disease after 3 days inoculation; (C) control. |
Commercial strains | Yield (kg m−2) | Disease incidence (%) | Resistance levela | Wild strains | Yield (kg m−2) | Disease incidence (%) | Resistance levela |
---|---|---|---|---|---|---|---|
a 0 = No disease development (immune, I); 1–10% disease severity (resistant, R); 11–30% disease severity (moderately susceptible, MS); >30% disease severity (susceptible, S). Values in the same column with the same following letters do not significantly differ (p < 0.05); ±standard deviation. | |||||||
CCMJ1009 | 8.92 ± 0.375a | 32.06 ± 4.642ab | S | CCMJ1110 | 8.22 ± 0.174b | 17.67 ± 5.776defghij | MS |
CCMJ1109 | 8.07 ± 0.264abc | 37.84 ± 6.111a | S | CCMJ1350 | 6.09 ± 0.487efgh | 15.75 ± 6.337defghij | MS |
CCMJ1343 | 7.83 ± 0.706abcd | 17.86 ± 3.990defghij | MS | CCMJ1384 | 6.08 ± 0.419efgh | 8.28 ± 4.164ij | R |
CCMJ1352 | 7.61 ± 0.160bcd | 27.73 ± 3.361abcd | MS | CCMJ1351 | 6.04 ± 0.459efgh | 6.49 ± 4.464j | R |
CCMJ1020 | 7.56 ± 0.678bcd | 19.52 ± 0.621cdefghi | MS | CCMJ1374 | 5.41 ± 0.902ghijk | 13.08 ± 7.278ghij | MS |
CCMJ1033 | 6.99 ± 0.809cde | 16.00 ± 3.912fghij | MS | CCMJ1363 | 5.36 ± 0.681ghijk | 10.84 ± 6.394hij | MS |
CCMJ1035 | 6.96 ± 0.091de | 30.55 ± 7.392abc | S | CCMJ1347 | 5.29 ± 0.262ghijk | 24.88 ± 1.995bcdefg | MS |
CCMJ1013 | 6.75 ± 0.667def | 30.63 ± 6.143abc | S | CCMJ1361 | 5.13 ± 0.591hijkl | 15.58 ± 4.472efghij | MS |
CCMJ1039 | 6.35 ± 0.650efg | 25.95 ± 5.703abcdef | MS | CCMJ1369 | 5.04 ± 0.232hijkl | 25.04 ± 7.291bcdefg | MS |
CCMJ1021 | 6.26 ± 0.796efg | 27.46 ± 5.635abcde | MS | CCMJ1379 | 4.92 ± 0.314ijkl | 20.63 ± 9.440bcdefgh | MS |
CCMJ1053 | 5.80 ± 0.557fghi | 25.48 ± 1.397bcdef | MS | CCMJ1377 | 4.72 ± 0.744ijkl | 21.27 ± 7.860bcdefgh | MS |
CCMJ1018 | 5.56 ± 0.926ghij | 19.12 ± 5.679cdefghi | MS | CCMJ1372 | 4.71 ± 0.188ijkl | 18.61 ± 8.935cdefghi | MS |
CCMJ1038 | 5.42 ± 0.540ghijk | 22.40 ± 2.510bcdefgh | MS | CCMJ1360 | 4.61 ± 0.835jkl | 19.62 ± 3.799cdefghi | MS |
CCMJ1028 | 5.39 ± 0.342ghijk | 21.33 ± 6.398bcdefgh | MS | CCMJ1106 | 4.46 ± 0.233kl | 12.36 ± 8.757hij | MS |
CCMJ1037 | 5.35 ± 0.487ghijk | 26.22 ± 4.306abcdef | MS | CCMJ1381 | 4.16 ± 0.337l | 19.64 ± 11.674cdefghi | MS |
Fig. 4 The resistance level of A. bisporus strains to cobweb disease. (A) Susceptible strain; (B) moderately susceptible strain; (C) resistant strain. |
The two resistant (R) strains CCMJ1351 and CCMJ1384 formed primordia and fruiting bodies that exhibited only small damage, while normal growth was observed in the control treatments (un-inoculated). These two resistant strains were wild collections from southeast of Tibet in China. These findings demonstrated the importance of the wild germplasm from Tibet as sources of resistance to cobweb disease.
In terms of the commercial A. bisporus strains, CCMJ1009, CCMJ1018, CCMJ1035, CCMJ1038, CCMJ1109, and CCMJ1352 demonstrated highly significant (P < 0.01) yield loss, and the three strains CCMJ1028, CCMJ1037, and CCMJ1053 showed significant (P < 0.05) yield loss, while the rest of the commercial strains exhibited statistically non-significant (P > 0.05) yield loss (Table S1†). Similarly, of the wild A. bisporus strains, CCMJ1106, CCMJ1110, and CCMJ1347 demonstrated highly significant (P < 0.01) yield loss, and CCMJ1369, CCMJ1372, and CCMJ1381 exhibited significant (P < 0.05) yield loss, while the remainder of the wild strains displayed statistically non-significant (P > 0.05) yield loss (Table S1†). A commercial A. bisporus strain CCMJ1109 consistently demonstrated maximum yield loss (37.96%), followed by CCMJ1009 (31.06%) and CCMJA1035 (30.76%), while a wild strain CCMJ1351 (6.81%) showed (Fig. 5) the lowest yield loss followed by CCMJ1384 (8.52%) and CCMJ1363 (11.81%).
For further insight into the structural properties of the botanicals, the FTIR spectrum of S. aromaticum was evaluated to identify the functional groups of the active components based on the peak value in the region of the infrared radiation. The FTIR analysis showed (Fig. 6B) a clear and maximum intensive peak at 3375 cm−1 that represents the OH groups; a moderate peak at 2852–2920 cm−1 that represents the frequency patterns of CH2 and CH3 groups; and a peak at 1730 cm−1 that represents an ester group C–O or aromatic ketone group CO. Another peak at 1643 cm−1 represents the aromatic carbonyl group belonging to quinine.29 The other frequency peaks at 1452 and 1402 cm−1 indicated the presence of a CH2 group, and a peak at 1070 cm−1 represented the C–O group. Moderate peaks at 779 and 919 cm−1 showed the frequency patterns of the CH2 and CC groups, respectively.30 The most prominent spectral bands as mentioned above mainly corresponding to the respective major antifungal compounds. Thus, the FTIR analysis identified novel phytochemical markers that could constitute useful analytical tools for assessing the quality of the sample and identifying the presence of functional groups in S. aromaticum. We could further isolate and screen for different biological activities depending on their antifungal uses.
The wild strains of A. bisporus contained more genetic diversity than the commercial cultivars.12 However, no previous reports regarding the resistance/susceptibility and yield losses of cobweb disease on wild strains exist. Our results indicated clear differences in yield losses between the A. bisporus strains (Fig. 4). To obtain a broader analysis of A. bisporus resistance to cobweb disease, we used cultivated strains and new germplasm resources from the wild strains that occur naturally in the harsh environment. This is the first report regarding the evaluation of the resistance of wild and commercial A. bisporus strains to cobweb disease. Previous studies showed that the wild resources of A. bisporus in the Tibetan Plateau of China have a high degree of variation in resistance to wet bubble disease (WBD), and 10 wild strains were highly resistant to WBD caused by Hypomyces perniciosus (formerly Mycogone perniciosa).12 However, we only found two strains that were resistant to cobweb disease caused by C. mycophilum. Of these two strains, we previously found CCMJ1351 to be highly resistant to WBD. We suggest that CCMJ1351 can be used for the breeding of highly disease-resistant cultivars.
Cobweb disease was observed in every flush, but maximum crop damage was observed during the third flush irrespective of the commercial or wild strain, as the disease incidence increased with crop age.6 However, there was a late appearance of the disease in the wild strains in comparison to the commercial strains, and two wild strains from China exhibited resistance against the cobweb disease pathogen. The results of this study provide useful information regarding the response of commercial and wild germplasm resources of A. bisporus to cobweb disease as well as potential wild germplasm resources for disease resistance.
According to previous reports, yield losses caused by cobweb disease in commercial A. bisporus strains vary from 10–29% to 22–62%.35,36 The environmental conditions during the experimental period and the strains of cobweb pathogen used might be responsible for these differences. It should be emphasized that there were insufficient data and studies available on the resistant and susceptible strains of A. bisporus towards Cladobotryum. The current investigation elucidated the resistant and susceptible wild and commercial A. bisporus strains that might have implications for future breeding programs and the selection of strains for the commercial cultivation of button mushroom and for the management of cobweb disease outbreaks.
The identification of new fungicides that are effective and biodegradable and exhibit increased selectivity is necessary for reducing the use of phytotoxic chemicals. Natural plant-derived products are comparatively safer and could be integrated into disease management programs as they possess antifungal activity without being phytotoxic.37 In this study, clove was found to be highly effective at inhibiting the growth of C. mycophilum. Earlier studies discovered that clove extract was highly active against many fungal genera, such as Aspergillus, Cladosporium, Penicillium, Rhizopus, and Saccharomyces, which is in accordance with our study.38,39 Our results corroborate those of previous studies where clove and cinnamon essential oils were able to suppress mycopathogens, with clove oil exhibiting greater toxicity than cinnamon to Lecanicillium fungicola and Cladobotryum dendroides.40
The bio-efficacy of botanicals is attributed to the fact that they have active compounds, such as azadirachtin, allicin, and salicin, which exhibit antifungal, antibacterial, and anti-insecticidal properties in nature.41 Some research has also reported that botanical extracts and oils used in different concentrations can effectively control the mycelial growth of mycopathogens.42–44 Clove oil contains eugenol up to 70–85% which is a phenolic compound with high antimicrobial activity.40 The antifungal activity of the botanicals in the present study might be due to the presence of one or more bioactive compounds, such as alkaloids, glycosides, flavonoids, steroids, and saponins.45 The maximum intensive peak observed at 3375 cm−1 represented the OH groups; a peak at 1730 cm−1 and 1070 cm−1 represented the group C–O that is the characteristic band for alcohols and phenols; and a peak at 1643 cm−1 represented the aromatic carbonyl group belonging to quinine. Therefore, clove contains various bioactive components with a high degree of antifungal activity against the cobweb disease pathogen. Our study provides a foundation for the use of some compounds as new and more potent natural antifungal products, as FTIR spectroscopy has been proved to be a reliable and sensitive method for the detection of biomolecular composition.46 Further in vivo study is in progress for screening of botanicals for cobweb disease management and detailed identification and application of bioactive compounds.
Footnote |
† Electronic supplementary information (ESI) available: Table S1: comparison between the control and inoculated (C. mycophilum) treatments regarding yield loss for wild and commercial strains of A. bisporus, Fig. S2: screening of botanicals. See DOI: 10.1039/c9ra00632j |
This journal is © The Royal Society of Chemistry 2019 |